Pre-clinical study results demonstrated that BONESUPPORT’s CERAMENT™, loaded with rhBMP-2 + zoledronic acid in very low doses, was able to quantitatively/qualitatively generate a high amount of mineralized bone volume.
K2M received FDA 510(k) clearances to market CASCADIA™ Cervical and CASCADIA AN Lordotic Oblique Interbody systems, featuring Lamellar 3D-printed Titanium Technology™.
CollPlant received governmental authorization in Israel for funding of various 2016 development projects, including support of products to treat torn and inflamed tendons/ligaments.
MX Orthopedics was awarded a state-backed US $0.75MM Accelerator Loan. Funds will support commercialization of dynaMX™ superelastic orthopaedic fracture fixation implants.